phentolamine has been researched along with Night Blindness in 1 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Night Blindness: Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Pepose, J | 1 |
Brigell, M | 1 |
Lazar, E | 1 |
Heisel, C | 1 |
Yousif, J | 1 |
Rahmani, K | 1 |
Kolli, A | 1 |
Hwang, M | 1 |
Mitrano, C | 1 |
Lazar, A | 1 |
Charizanis, K | 1 |
Sooch, M | 1 |
McDonald, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances[NCT04004507] | Phase 2 | 24 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for phentolamine and Night Blindness
Article | Year |
---|---|
A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.
Topics: Adult; Contrast Sensitivity; Female; Glare; Humans; Hyperemia; Male; Middle Aged; Night Blindness; N | 2022 |